DMAA
Drugs Made In America Acquisition Corp
DMAA
DMAA
37 hedge funds and large institutions have $223M invested in Drugs Made In America Acquisition Corp in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2.79% more ownership
Funds ownership: 62.13% → 64.91% (+2.8%)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Holders
37
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.13M | |
| 2 | +$4.12M | |
| 3 | +$3.27M | |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
+$2.57M |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$2.33M |
Top Sellers
| 1 | -$3.57M | |
| 2 | -$2.57M | |
| 3 | -$2.02M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.52M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.02M |
